FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2343996416> ?p ?o ?g. }

• W2343996416 endingPage "661" @default.
• W2343996416 startingPage "637" @default.
• W2343996416 abstract "Casticin, a polymethoxyflavone occurring in natural plants, has been shown to have anticancer activities. In the present study, we aims to investigate the anti-skin cancer activity of casticin on melanoma cells in vitro and the antitumor effect of casticin on human melanoma xenografts in nu/nu mice in vivo. A flow cytometric assay was performed to detect expression of viable cells, cell cycles, reactive oxygen species production, levels of [Formula: see text] and caspase activity. A Western blotting assay and confocal laser microscope examination were performed to detect expression of protein levels. In the in vitro studies, we found that casticin induced morphological cell changes and DNA condensation and damage, decreased the total viable cells, and induced G2/M phase arrest. Casticin promoted reactive oxygen species (ROS) production, decreased the level of [Formula: see text], and promoted caspase-3 activities in A375.S2 cells. The induced G2/M phase arrest indicated by the Western blotting assay showed that casticin promoted the expression of p53, p21 and CHK-1 proteins and inhibited the protein levels of Cdc25c, CDK-1, Cyclin A and B. The casticin-induced apoptosis indicated that casticin promoted pro-apoptotic proteins but inhibited anti-apoptotic proteins. These findings also were confirmed by the fact that casticin promoted the release of AIF and Endo G from mitochondria to cytosol. An electrophoretic mobility shift assay (EMSA) assay showed that casticin inhibited the NF-[Formula: see text]B binding DNA and that these effects were time-dependent. In the in vivo studies, results from immuno-deficient nu/nu mice bearing the A375.S2 tumor xenograft indicated that casticin significantly suppressed tumor growth based on tumor size and weight decreases. Early G2/M arrest and mitochondria-dependent signaling contributed to the apoptotic A375.S2 cell demise induced by casticin. In in vivo experiments, A375.S2 also efficaciously suppressed tumor volume in a xenotransplantation model. Therefore, casticin might be a potential therapeutic agent for the treatment of skin cancer in the future." @default.
• W2343996416 created "2016-06-24" @default.
• W2343996416 creator A5005095369 @default.
• W2343996416 creator A5012435435 @default.
• W2343996416 creator A5015171685 @default.
• W2343996416 creator A5015447797 @default.
• W2343996416 creator A5017303641 @default.
• W2343996416 creator A5038848714 @default.
• W2343996416 creator A5057175677 @default.
• W2343996416 creator A5057929659 @default.
• W2343996416 creator A5083601383 @default.
• W2343996416 creator A5087091914 @default.
• W2343996416 date "2016-01-01" @default.
• W2343996416 modified "2023-09-23" @default.
• W2343996416 title "Casticin Induced Apoptosis in A375.S2 Human Melanoma Cells through the Inhibition of NF-κB and Mitochondria-Dependent Pathways <i>In Vitro</i> and Inhibited Human Melanoma Xenografts in a Mouse Model <i>In Vivo</i>" @default.
• W2343996416 cites W1522773084 @default.
• W2343996416 cites W163606371 @default.
• W2343996416 cites W1965319671 @default.
• W2343996416 cites W1971511577 @default.
• W2343996416 cites W1971574001 @default.
• W2343996416 cites W1972516276 @default.
• W2343996416 cites W1975471655 @default.
• W2343996416 cites W1976664795 @default.
• W2343996416 cites W1984131697 @default.
• W2343996416 cites W1985339713 @default.
• W2343996416 cites W1997919830 @default.
• W2343996416 cites W2002449811 @default.
• W2343996416 cites W2010055562 @default.
• W2343996416 cites W2023261795 @default.
• W2343996416 cites W2028494050 @default.
• W2343996416 cites W2035210716 @default.
• W2343996416 cites W2036453111 @default.
• W2343996416 cites W2045658350 @default.
• W2343996416 cites W2056536159 @default.
• W2343996416 cites W2059277863 @default.
• W2343996416 cites W2061690334 @default.
• W2343996416 cites W2062147317 @default.
• W2343996416 cites W2063205344 @default.
• W2343996416 cites W2068237418 @default.
• W2343996416 cites W2071515199 @default.
• W2343996416 cites W2076781302 @default.
• W2343996416 cites W2086933069 @default.
• W2343996416 cites W2087877138 @default.
• W2343996416 cites W2094641040 @default.
• W2343996416 cites W2094913016 @default.
• W2343996416 cites W2104553571 @default.
• W2343996416 cites W2104695873 @default.
• W2343996416 cites W2112452260 @default.
• W2343996416 cites W2129242841 @default.
• W2343996416 cites W2141095602 @default.
• W2343996416 cites W2154928200 @default.
• W2343996416 cites W2158101161 @default.
• W2343996416 cites W2163375435 @default.
• W2343996416 cites W2168373244 @default.
• W2343996416 cites W2169319168 @default.
• W2343996416 cites W2323314832 @default.
• W2343996416 cites W2999065750 @default.
• W2343996416 cites W4214942360 @default.
• W2343996416 cites W4379365691 @default.
• W2343996416 doi "https://doi.org/10.1142/s0192415x1650035x" @default.
• W2343996416 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27109154" @default.
• W2343996416 hasPublicationYear "2016" @default.
• W2343996416 type Work @default.
• W2343996416 sameAs 2343996416 @default.
• W2343996416 citedByCount "17" @default.
• W2343996416 countsByYear W23439964162017 @default.
• W2343996416 countsByYear W23439964162018 @default.
• W2343996416 countsByYear W23439964162019 @default.
• W2343996416 countsByYear W23439964162020 @default.
• W2343996416 countsByYear W23439964162022 @default.
• W2343996416 countsByYear W23439964162023 @default.
• W2343996416 crossrefType "journal-article" @default.
• W2343996416 hasAuthorship W2343996416A5005095369 @default.
• W2343996416 hasAuthorship W2343996416A5012435435 @default.
• W2343996416 hasAuthorship W2343996416A5015171685 @default.
• W2343996416 hasAuthorship W2343996416A5015447797 @default.
• W2343996416 hasAuthorship W2343996416A5017303641 @default.
• W2343996416 hasAuthorship W2343996416A5038848714 @default.
• W2343996416 hasAuthorship W2343996416A5057175677 @default.
• W2343996416 hasAuthorship W2343996416A5057929659 @default.
• W2343996416 hasAuthorship W2343996416A5083601383 @default.
• W2343996416 hasAuthorship W2343996416A5087091914 @default.
• W2343996416 hasConcept C104317684 @default.
• W2343996416 hasConcept C105696609 @default.
• W2343996416 hasConcept C124320809 @default.
• W2343996416 hasConcept C150903083 @default.
• W2343996416 hasConcept C153911025 @default.
• W2343996416 hasConcept C185592680 @default.
• W2343996416 hasConcept C190283241 @default.
• W2343996416 hasConcept C202751555 @default.
• W2343996416 hasConcept C207001950 @default.
• W2343996416 hasConcept C29537977 @default.
• W2343996416 hasConcept C48349386 @default.
• W2343996416 hasConcept C553184892 @default.
• W2343996416 hasConcept C55493867 @default.
• W2343996416 hasConcept C85265743 @default.
• W2343996416 hasConcept C86803240 @default.
• W2343996416 hasConcept C95444343 @default.

• next